Strong patient interest in the only federally approved CBD product in the United States helped drugmaker\u00a0GW Pharmaceuticals record $72 million in revenue last quarter. Epidiolex, which is made by London\u2019s\u00a0GW Pharma\u00a0(Nasdaq:\u00a0GWPH), is a seizure control drug approved by the U.S. Food and Drug Administration. It has seen brisk sales and new patient enrollments since the [\u2026]<\/p>\n
\u2018Pent-up demand\u2019 for FDA-approved cannabis drug boosts UK maker<\/a> is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs<\/a><\/p>\n
Strong patient interest in the only federally approved CBD product in the United States helped drugmaker\u00a0GW Pharmaceuticals record $72 million in revenue last quarter. Epidiolex, which is made by London\u2019s\u00a0GW Pharma\u00a0(Nasdaq:\u00a0GWPH), is a seizure control drug approved by the U.S. Food and Drug Administration. It has seen brisk sales andContinue Reading<\/a><\/span><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"false","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[9662,3157,2043,2786,8948,9663],"tags":[],"_links":{"self":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/37347"}],"collection":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/comments?post=37347"}],"version-history":[{"count":1,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/37347\/revisions"}],"predecessor-version":[{"id":37348,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/37347\/revisions\/37348"}],"wp:attachment":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media?parent=37347"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/categories?post=37347"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/tags?post=37347"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n
\nRead More: \u2018Pent-up demand\u2019 for FDA-approved cannabis drug boosts UK maker<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"